1
|
Martino J, Sebert S, Segura MT, García-Valdés L, Florido J, Padilla MC, Marcos A, Rueda R, McArdle HJ, Budge H, Symonds ME, Campoy C. Maternal Body Weight and Gestational Diabetes Differentially Influence Placental and Pregnancy Outcomes. J Clin Endocrinol Metab 2016; 101:59-68. [PMID: 26513002 PMCID: PMC4701853 DOI: 10.1210/jc.2015-2590] [Citation(s) in RCA: 76] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
CONTEXT Maternal obesity and gestational diabetes mellitus (GDM) can both contribute to adverse neonatal outcomes. The extent to which this may be mediated by differences in placental metabolism and nutrient transport remains to be determined. OBJECTIVE Our objective was to examine whether raised maternal body mass index (BMI) and/or GDM contributed to a resetting of the expression of genes within the placenta that are involved in energy sensing, oxidative stress, inflammation, and metabolic pathways. METHODS Pregnant women from Spain were recruited as part of the "Study of Maternal Nutrition and Genetics on the Foetal Adiposity Programming" survey at the first antenatal visit (12-20 weeks of gestation) and stratified according to prepregnancy BMI and the incidence of GDM. At delivery, placenta and cord blood were sampled and newborn anthropometry measured. RESULTS Obese women with GDM had higher estimated fetal weight at 34 gestational weeks and a greater risk of preterm deliveries and cesarean section. Birth weight was unaffected by BMI or GDM; however, women who were obese with normal glucose tolerance had increased placental weight and higher plasma glucose and leptin at term. Gene expression for markers of placental energy sensing and oxidative stress, were primarily affected by maternal obesity as mTOR was reduced, whereas SIRT-1 and UCP2 were both upregulated. In placenta from obese women with GDM, gene expression for AMPK was also reduced, whereas the downstream regulator of mTOR, p70S6KB1 was raised. CONCLUSIONS Placental gene expression is sensitive to both maternal obesity and GDM which both impact on energy sensing and could modulate the effect of either raised maternal BMI or GDM on birth weight.
Collapse
Affiliation(s)
- J Martino
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - S Sebert
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - M T Segura
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - L García-Valdés
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - J Florido
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - M C Padilla
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - A Marcos
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - R Rueda
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - H J McArdle
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - H Budge
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - M E Symonds
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - C Campoy
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| |
Collapse
|
2
|
Al-Hashimi LM, Gambling L, McArdle HJ. The Effect of Iron Deficiency on Osmotic Sensitivity of Red Blood Cells from Neonatal Rats and Their Mothers. J Membr Biol 2015; 248:1199-206. [PMID: 26439821 DOI: 10.1007/s00232-015-9841-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2015] [Accepted: 09/06/2015] [Indexed: 12/01/2022]
Abstract
Iron deficiency during pregnancy has many effects on both the mother and her developing foetus. These can be both short and long term. One effect is an alteration in fatty acid metabolism and we hypothesised that these changes may result in alterations in membrane function and structure. In order to test this hypothesis, we measured osmotic sensitivity in red blood cells isolated from neonates and their mothers at different times following birth. We fed female rats control or iron-deficient diets for 4 weeks prior to mating and kept them on the same diet until term. At that time, we returned one group of deficient dams to the control diet. The others were kept on the same diet. We showed that iron deficiency results in a decrease in osmotic sensitivity in the mothers but not in their neonates. Returning the dams to the control diet resulted in a return of their red cell osmotic sensitivity to control levels. In the neonates, there was no recovery in haematocrit or in any other parameter, though they did not get any worse, in contrast to the pups being suckled by deficient mothers. The data show two things. The first is that following birth, the mother restores her own iron stores at the expense of the pups, and secondly, there are differences in properties and sensitivities between red cells from mothers and their neonates. This latter observation cannot be explained by differences in the membrane fatty acid profiles, which were not significantly different.
Collapse
Affiliation(s)
- L Mossa Al-Hashimi
- Rowett Institute of Nutrition and Health, University of Aberdeen, Greenburn Road, Bucksburn, Aberdeen, AB21 9SB, UK
| | - Lorraine Gambling
- Rowett Institute of Nutrition and Health, University of Aberdeen, Greenburn Road, Bucksburn, Aberdeen, AB21 9SB, UK.
| | - H J McArdle
- Rowett Institute of Nutrition and Health, University of Aberdeen, Greenburn Road, Bucksburn, Aberdeen, AB21 9SB, UK.
| |
Collapse
|
3
|
Garcia-Valdes L, Campoy C, Hayes H, Florido J, Rusanova I, Miranda MT, McArdle HJ. The impact of maternal obesity on iron status, placental transferrin receptor expression and hepcidin expression in human pregnancy. Int J Obes (Lond) 2015; 39:571-8. [PMID: 25614087 DOI: 10.1038/ijo.2015.3] [Citation(s) in RCA: 108] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/27/2014] [Revised: 11/08/2014] [Accepted: 12/16/2014] [Indexed: 01/07/2023]
Abstract
BACKGROUND Obesity is associated with decreased iron status, possibly due to a rise in hepcidin, an inflammatory protein known to reduce iron absorption. In animals, we have shown that maternal iron deficiency is minimised in the foetus by increased expression of placental transferrin receptor (pTFR1), resulting in increased iron transfer at the expense of maternal iron stores. OBJECTIVE This study examines the effect of obesity during pregnancy on maternal and neonatal iron status in human cohorts and whether the placenta can compensate for decreased maternal iron stores by increasing pTFR1 expression. SUBJECTS/METHODS A total of 240 women were included in this study. One hundred and fifty-eight placentas (Normal: 90; Overweight: 37; Obese: 31) were collected at delivery. Maternal iron status was measured by determining serum transferrin receptor (sTFR) and ferritin levels at 24 and 34 weeks and at delivery. Hepcidin in maternal and cord blood was measured by ELISA and pTFR1 in placentas by western blotting and real-time RT-PCR. RESULTS Low iron stores were more common in obese women. Hepcidin levels (ng ml(-1)) at the end of the pregnancy were higher in obese than normal women (26.03±12.95 vs 18.00±10.77, P<0.05). Maternal hepcidin levels were correlated with maternal iron status (sTFR r=0.2 P=0.025), but not with neonatal values. mRNA and protein levels of pTFR1 were both inversely related to maternal iron status. For mRNA and all women, sTFR r=0.2 P=0.044. Ferritin mRNA levels correlated only in overweight women r=-0.5 P=0.039 with hepcidin (r=0.1 P=0.349), irrespective of maternal body mass index (BMI). CONCLUSIONS The data support the hypothesis that obese pregnant women have a greater risk of iron deficiency and that hepcidin may be a regulatory factor. Further, we show that the placenta responds to decreased maternal iron status by increasing pTFR1 expression.
Collapse
Affiliation(s)
- L Garcia-Valdes
- 1] The Rowett Institute of Nutrition and Health, University of Aberdeen, Bucksburn, Aberdeen, UK [2] Department of Paediatrics, School of Medicine, University of Granada, Granada, Spain
| | - C Campoy
- Department of Paediatrics, School of Medicine, University of Granada, Granada, Spain
| | - H Hayes
- The Rowett Institute of Nutrition and Health, University of Aberdeen, Bucksburn, Aberdeen, UK
| | - J Florido
- Department Obstetrics and Gynaecology, School of Medicine, University of Granada, Granada, Spain
| | - I Rusanova
- Department of Paediatrics, School of Medicine, University of Granada, Granada, Spain
| | - M T Miranda
- Department of Biostatistics, School of Medicine, University of Granada, Granada, Spain
| | - H J McArdle
- The Rowett Institute of Nutrition and Health, University of Aberdeen, Bucksburn, Aberdeen, UK
| |
Collapse
|
4
|
Alwan NA, Lawlor DA, McArdle HJ, Greenwood DC, Cade JE. OP61 Is Maternal Iron Status Associated with offspring’s Blood Pressure and Adiposity? A Mendelian Randomization Study. Br J Soc Med 2012. [DOI: 10.1136/jech-2012-201753.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
5
|
Alwan NA, Greenwood DC, Simpson NAB, McArdle HJ, Cade JE. The relationship between dietary supplement use in late pregnancy and birth outcomes: a cohort study in British women. BJOG 2010; 117:821-9. [PMID: 20353456 PMCID: PMC2874518 DOI: 10.1111/j.1471-0528.2010.02549.x] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Objective To examine the relationship between dietary supplement use during pregnancy and birth outcomes. Design A prospective birth cohort. Setting Leeds, UK. Sample One thousand two hundred and seventy-four pregnant women aged 18–45 years. Methods Dietary supplement intake was ascertained using three questionnaires for the first, second and third trimesters. Dietary intake was reported in a 24-hour dietary recall administered by a research midwife at 8–12 weeks of gestation. Information on delivery details and antenatal pregnancy complications was obtained from the hospital maternity records. Main outcome measures Birthweight, birth centile and preterm birth. Results Reported dietary supplement use declined from 82% of women in the first trimester of pregnancy to 22% in the second trimester and 33% in the third trimester. Folic acid was the most commonly reported supplement taken. Taking any type of daily supplement during any trimester was not significantly associated with size at birth taking into account known relevant confounders. Women taking multivitamin-mineral supplements in the third trimester were more likely to experience preterm birth (adjusted OR = 3.4, 95% CI 1.2, 9.6, P= 0.02). Conclusions Regular multivitamin–mineral supplement use during pregnancy, in a developed country setting, is not associated with size at birth. However, it appears to be associated with preterm birth if taken daily in the third trimester. The mechanism for this is unclear and our study’s findings need confirming by other cohorts and/or trials in developed countries.
Collapse
Affiliation(s)
- N A Alwan
- Nutritional Epidemiology Group, Centre for Epidemiology and Biostatistics, University of Leeds, Leeds, UK.
| | | | | | | | | |
Collapse
|
6
|
Abstract
Iron and copper are both essential micronutrients and are required for a wide variety of enzymatic and other processes within the developing foetus. Transfer of both nutrients across the placenta is tightly regulated. In this review, we consider their mechanisms of transport, how the transfer is modulated in response to nutritional requirements and how the two metals interact. Iron uptake is via the transferrin receptor, followed by endocytosis, acidification of the vesicle, and release of the iron into the cytosol, and transfer across the basolateral membrane. Many of the genes involved have been identified, and, to varying extents, their mechanisms of regulation clarified, but there are still unanswered questions and conundrums. For example, although the ion channel DMT1 (now formally known as slc11a2) is essential for iron uptake in the gut, knockout mice, which have no slc11a2 protein, have apparently normal transfer across the placenta. There must, therefore, be an alternative mechanism, which remains unclear, although nonspecific calcium channels have been proposed as one possibility. For copper, uptake is a carrier-mediated process, and intracellular transfer is mediated by proteins known as chaperones. Efflux is through ATPases, but their localisation and how they are regulated is only now being elucidated. Regulation of copper proteins appears to be different from that of iron, with localisation of the protein, rather than changing levels, being responsible for altering rates of transfer. This may not be true for all the proteins and genes involved in the delivery of copper, and, again, there is much that remains to be clarified. Finally, we consider the interactions that occur between the two metals, reviewing the data that show how alterations in levels of one of the nutrients changes that of the other, and we examine the hypotheses explaining the interactions.
Collapse
|
7
|
Tilley RE, McNeil CJ, Ashworth CJ, Page KR, McArdle HJ. Altered muscle development and expression of the insulin-like growth factor system in growth retarded fetal pigs. Domest Anim Endocrinol 2007; 32:167-77. [PMID: 16564666 DOI: 10.1016/j.domaniend.2006.02.003] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/22/2005] [Revised: 02/09/2006] [Accepted: 02/11/2006] [Indexed: 11/17/2022]
Abstract
We have used a porcine model of spontaneous differential fetal growth to investigate the effects of fetal size on muscle development. We hypothesized that altered muscle development may occur in small fetuses as a consequence of modified expression of selected genes of the insulin-like growth factor system. We examined the development of the Longissimus muscle (m. Longissimus) in small fetuses and their average sized littermates. We collected small for gestational age fetuses and their average sized sibling on days 45, 65 and 100 of gestation (term is 113-116 days). Small fetuses had significantly lower body weight at all three stages of gestation (p<0.05) and significantly reduced secondary to primary muscle fibre ratio in m. Longissimus on day 100 (p<0.05) compared to their littermates. On day 65, the expression of insulin-like growth factor receptor 1 and insulin-like growth factor binding protein 3 were significantly higher (p<0.05) in m. Longissimus of the small fetuses compared with their average sized littermates. On day 100, the expression of insulin-like growth factor receptor 1 remained significantly higher (p=0.001), in addition to significantly higher levels of insulin-like growth factor receptor 2 and insulin-like growth factor binding protein 5 in the small fetuses (p<0.05). No difference in levels of myogenin was observed between the small and average sized littermates. In conclusion, we demonstrate that reduced fetal muscle development is associated with an increased expression of several genes of the insulin-like growth factor system in small fetuses in mid to late gestation.
Collapse
Affiliation(s)
- R E Tilley
- Rowett Research Institute, Bucksburn, Aberdeen, UK.
| | | | | | | | | |
Collapse
|
8
|
Jones HN, Ashworth CJ, Page KR, McArdle HJ. Expression and adaptive regulation of amino acid transport system A in a placental cell line under amino acid restriction. Reproduction 2006; 131:951-60. [PMID: 16672359 DOI: 10.1530/rep.1.00808] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Trans-placental transport of amino acids is vital for the developing fetus. Using the BeWo cell line as a placental model, we investigated the effect of restricting amino acid availability on amino acid transport system type A. BeWo cells were cultured either in amino acid-depleted (without non-essential amino acids) or control media for 1, 3, 5 or 6 h. System A function was analysed using alpha(methyl-amino)isobutyric acid (MeAIB) transcellular transport studies. Transporter (sodium coupled neutral amino acid transporter (SNAT1/2)) expression was analysed at mRNA and protein level by Northern and Western blotting respectively. Localisation was carried out using immunocytochemistry. MeAIB transcellular transport was significantly (P < 0.05) increased by incubation of the cells in amino acid-depleted medium for 1 h, and longer incubation times caused further increases in the rate of transfer. However, the initial response was not accompanied by an increase in SNAT2 mRNA; this occurred only after 3 h and further increased for the rest of the 6-h incubation. Similarly, it took several hours for a significant increase in SNAT2 protein expression. In contrast, relocalisation of existing SNAT2 transporters occurred within 30 min of amino acid restriction and continued throughout the 6-h incubation. When the cells were incubated in medium with even lower amino acid levels (without non-essential plus 0.5 x essential amino acids), SNAT2 mRNA levels showed further significant (P < 0.0001) up-regulation. However, incubation of cells in depleted medium for 6 h caused a significant (P = 0.014) decrease in the expression of SNAT1 mRNA. System L type amino acid transporter 2 (LAT2) expression was not changed by amino acid restriction, indicating that the responses seen in the system A transporters were not a general cell response. These data have shown that placental cells adapt in vitro to nutritional stress and have identified the physiological, biochemical and genomic mechanisms involved.
Collapse
Affiliation(s)
- H N Jones
- Maternal-Fetal Physiology, Rowett Research Institute, Greenburn Road, Bucksburn, Aberdeen AB21 9SB, UK
| | | | | | | |
Collapse
|
9
|
McArdle HJ, Andersen HS, Jones H, Gambling L. Fetal programming: causes and consequences as revealed by studies of dietary manipulation in rats -- a review. Placenta 2006; 27 Suppl A:S56-60. [PMID: 16533523 DOI: 10.1016/j.placenta.2006.01.014] [Citation(s) in RCA: 54] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/18/2005] [Revised: 01/06/2006] [Accepted: 01/19/2006] [Indexed: 10/24/2022]
Abstract
During pregnancy, the developing fetus is dependent on its mother for all nutritional requirements. It is not surprising, therefore, that variations in maternal nutrition can be reflected in alterations in fetal health and well-being. Interestingly, the changes can persist into adulthood and may result in increased risk of diseases such as diabetes, obesity and cardiovascular disease. The first observations of these phenomena resulted in the development of hypotheses collectively brought under the heading of "fetal" or, more recently, "developmental" programming. In this review, we will examine some of the animal models used to understand the mechanisms involved and attempt to determine whether there are common, "gatekeeper", pathways or genes, altered by the different nutritional stresses. We will concentrate primarily on nutrition related to post-natal development of hypertension and will restrict the review to studies in rodents, since that is where most of the mechanistic studies are being undertaken. Our conclusions are that, while there may well be some common gatekeeper pathways, there is also some diversity of mechanism which may contribute to the generation of the same or similar phenotypes.
Collapse
Affiliation(s)
- H J McArdle
- Rowett Research Institute, Greenburn Road, Bucksburn, Aberdeen AB21 9SB, UK.
| | | | | | | |
Collapse
|
10
|
Fosset C, McGaw BA, Reid MD, McArdle HJ. A non-radioactive method for measuring Cu uptake in HepG2 cells. J Inorg Biochem 2005; 99:1018-22. [PMID: 15833324 DOI: 10.1016/j.jinorgbio.2005.01.005] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2004] [Revised: 01/07/2005] [Accepted: 01/10/2005] [Indexed: 01/23/2023]
Abstract
At present, all data on Cu uptake and metabolism have been derived from radioactive uptake experiments. These experiments are limited by the availability of the radioactive isotopes 64Cu or 67Cu, and their short half-life (12.5 and 62 h, respectively). In this paper, we investigate an alternative method to study the uptake of Cu with natural isotopes in HepG2 cells, a liver cell line used extensively to study Cu metabolism. In nature, Cu occurs as two stable isotopes, 63Cu and 65Cu (63Cu/65Cu = 2.23). This ratio can be measured accurately using inductively coupled plasma mass spectrometry (ICP-MS). In initial experiments, we attempted to measure the time course of Cu uptake using 65Cu. The change in the 63Cu/65Cu ratio, however, was too small to allow measurement of Cu uptake by the cells. To overcome this difficulty, the natural 63Cu/65Cu ratio in HepG2 cells was altered using long-term incubation with 63Cu. This had a significant effect on Cu concentration in HepG2 cells, changing it from 81.9 +/- 9.46 pmol microg DNA(-1) (week 1) to 155 +/- 8.63 pmol microg DNA(-1) (week 2) and stabilising at 171 +/- 4.82 pmol microg DNA(-1) (week 3). After three weeks of culture with 2 microM 63Cu the 63Cu/65Cu changed from 2.18 +/- 0.05 to 15.3 +/- 1.01. Cu uptake was then investigated as before using 65Cu. Uptake was linear over 60 min, temperature dependent and consistent with previous kinetics data. These observations suggest that stable isotope ICP-MS provides an alternative technique for the study of Cu uptake by HepG2 cells.
Collapse
Affiliation(s)
- C Fosset
- The Rowett Research Institute, Bucksburn, Green Road, Aberdeen, Scotland AB21 9SB, UK
| | | | | | | |
Collapse
|
11
|
Gambling L, Andersen HS, Czopek A, Wojciak R, Krejpcio Z, McArdle HJ. Effect of timing of iron supplementation on maternal and neonatal growth and iron status of iron-deficient pregnant rats. J Physiol 2004; 561:195-203. [PMID: 15358806 PMCID: PMC1665338 DOI: 10.1113/jphysiol.2004.068825] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2004] [Accepted: 09/08/2004] [Indexed: 01/03/2023] Open
Abstract
We have previously shown that maternal iron (Fe) deficiency not only reduces fetal size, but also increases blood pressure in the offspring when they are adults. In this paper we examine whether there are critical periods when supplementation reverses or fails to reverse the effect both on size and on expression of genes of Fe metabolism. We made dams Fe deficient, mated them and provided supplements of Fe in the diet from the beginning of gestation (0.5 days), from 7.5 days or from 14.5 days. Within 12 h of birth, dams and neonates were killed and tissues taken and examined. Fe deficiency throughout pregnancy reduces neonatal size. Supplementation from the beginning of the first, second or third week all reduced the effect. Maternal haematocrit was restored to normal levels only in animals given supplements for at least 2 weeks. In contrast, the neonates' Fe levels were normal in all supplemented groups. These results were mirrored in liver Fe levels and in transferrin receptor mRNA. Iron-responsive element (IRE)-regulated divalent metal transporter 1 (DMT1) increased in maternal and neonatal liver. Non-IRE-regulated DMT1 levels did not change in the maternal liver, but decreased in the neonatal liver. H and L ferritin mRNA levels also showed different patterns in the mother and her offspring. Finally, the neonatal size correlated with maternal Fe stores, and not with those of the fetus. The data demonstrate that Fe supplementation during pregnancy is most effective when given early, rather than later, in gestation.
Collapse
Affiliation(s)
- L Gambling
- Rowett Research Institute, Greenburn Road, Bucksburn, Aberdeen AB21 9SB, UK
| | | | | | | | | | | |
Collapse
|
12
|
Page KR, Ashworth CJ, McArdle HJ, Finch AM, Nwagwu MO. Sodium transport across the chorioallantoic membrane of porcine placenta involves the epithelial sodium channel (ENaC). J Physiol 2003; 547:849-57. [PMID: 12562966 PMCID: PMC2342719 DOI: 10.1113/jphysiol.2002.031153] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2002] [Accepted: 01/02/2003] [Indexed: 11/08/2022] Open
Abstract
The properties of chorioallantoic membrane derived from Large White Landrace sows at 45, 65 and 100 days gestation are examined. Under short circuit conditions positive charge flows from fetal to maternal sides of the tissue. Na+ is shown to be the sole charge carrier as the short circuit current is inhibited reversibly by fetal applications of amiloride and replacement of Na+ by choline in the Ringer solution, and irreversibly by both fetal and maternal applications of ouabain. The initial short circuit current is smaller at day 100 compared to days 45 and 65. The dose responses to amiloride indicate that the epithelial sodium channel (ENaC) is involved in the movement of Na+ and that it is accessible on the fetal side of the tissue only. Immunostaining shows that the ENaC-alpha subunit is present in both the allantoic membrane and the trophoblast. Uptake studies using microvillous (apical) membrane vesicles suggest it is either inactive or only weakly active at this site. The trophoblast at day 100 has a higher content of ENaC than at days 45 and 65. This is the first report of the presence of ENaC in placental tissues. The effects of ouabain indicate the presence of a Na+ pump that is more readily inhibited by applications of the drug on the maternal aspect of the tissue than on the fetal side. Differential mechanisms may be present that would allow net movement of Na+ in either direction across the chorioallantoic membrane according to the changing demands of the developing fetus.
Collapse
Affiliation(s)
- K R Page
- Department of Biomedical Sciences, Aberdeen University, Scottish Agricultural College, Craibstone and Rowett Research Institute, Aberdeen, UK.
| | | | | | | | | |
Collapse
|
13
|
McArdle HJ, Danzeisen R, Fosset C, Gambling L. The role of the placenta in iron transfer from mother to fetus and the relationship between iron status and fetal outcome. Biometals 2003; 16:161-7. [PMID: 12572675 DOI: 10.1023/a:1020714915767] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
During pregnancy, iron is transferred from the mother to the fetus across the placenta. The mechanism has been extensively studied. Altered iron metabolism changes transfer, but also has other consequences. In this review, we examine how the placenta adapts to altered iron supply, both in terms of changing cytokine expression and in relation to the proteins of iron transfer. Changing iron levels alters the levels of other metals, especially copper, and we review how this is related to changing function. There are also consequences to the placenta itself, to vascularisation and other aspects of the physiology. In turn, this has effects on the fetus and we review how growth and development are modified. Finally, we examine in more detail the efflux process, how it is regulated and, especially, the putative role of the placental Cu oxidase in the efflux process. As appropriate, we draw on data from humans, from animal models and from cell culture systems to illustrate the information.
Collapse
Affiliation(s)
- H J McArdle
- The Rowett Research Institute, Greenburn Road, Bucksburn, Aberdeen, AB21 9SB, UK.
| | | | | | | |
Collapse
|
14
|
Ashworth CJ, Finch AM, Page KR, Nwagwu MO, McArdle HJ. Causes and consequences of fetal growth retardation in pigs. Reprod Suppl 2002; 58:233-46. [PMID: 11980193] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/24/2023]
Abstract
In pigs, as in other species, fetal growth retardation is associated with reduced birth weight and increased risk of fetal and neonatal death. As there are few opportunities after birth to remedy the detrimental effects of low birth weight, it is important to understand both the intrinsic and extrinsic factors associated with inadequate fetal growth and to determine when growth retarded fetuses deviate from the growth trajectory of their normal sized littermates. Inadequately grown pig fetuses can be identified statistically as early as day 30 of the 114 days of gestation, indicating that limited uterine space is not a primary determinant of fetal growth. Comparisons of the smallest fetus within a litter with a normal sized sibling reveal that inadequately grown fetuses have altered endocrine status and lower circulating concentrations of many essential amino acids. In addition, the placenta supplying the smallest fetus is disproportionately small and has a reduced capacity to transport amino acids. Understanding the timing and the causes of fetal growth retardation in pigs may help us to devise appropriate strategies to reduce the incidence and hence the detrimental postnatal consequences of runting.
Collapse
Affiliation(s)
- C J Ashworth
- Animal Biology Division, SAC, Craibstone Estate, Bucksburn, Aberdeen AB21 9YA, UK.
| | | | | | | | | |
Collapse
|
15
|
Gambling L, Danzeisen R, Gair S, Lea RG, Charania Z, Solanky N, Joory KD, Srai SK, McArdle HJ. Effect of iron deficiency on placental transfer of iron and expression of iron transport proteins in vivo and in vitro. Biochem J 2001; 356:883-9. [PMID: 11389698 PMCID: PMC1221917 DOI: 10.1042/0264-6021:3560883] [Citation(s) in RCA: 75] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
Maternal iron deficiency during pregnancy induces anaemia in the developing fetus; however, the severity tends to be less than in the mother. The mechanism underlying this resistance has not been determined. We have measured placental expression of proteins involved in iron transfer in pregnant rats given diets with decreasing levels of iron and examined the effect of iron deficiency on iron transfer across BeWo cell layers, a model for placental iron transfer. Transferrin receptor expression was increased at both mRNA and protein levels. Similarly, expression of the iron-responsive element (IRE)-regulated form of the divalent metal transporter 1 (DMT1) was also increased. In contrast, the non-IRE regulated isoform showed no change in mRNA levels. Protein levels of DMT1 increased significantly. Iron efflux is thought to be mediated by the metal transporter protein, IREG1/ferroportin1/MTP1, and oxidation of Fe(II) to Fe(III) prior to incorporation into fetal transferrin is carried out by the placental copper oxidase. Expression of IREG1 was not altered by iron deficiency, whereas copper oxidase activity was increased. In BeWo cells made iron deficient by treatment with desferrioxamine ('deferioxamine'), iron accumulation from iron-transferrin increased, in parallel with increased expression of the transferrin receptor. At the same time, iron efflux also increased, showing a higher flux of iron from the apical to the basolateral side. The data show that expression of placental proteins of iron transport are up-regulated in maternal iron deficiency, resulting in an increased efficiency of iron flux and a consequent minimization of the severity of fetal anaemia.
Collapse
Affiliation(s)
- L Gambling
- The Rowett Research Institute, Greenburn Road, Bucksburn, Aberdeen AB21 9SB, Scotland, UK
| | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Danzeisen R, Ponnambalam S, Lea RG, Page K, Gambling L, McArdle HJ. The effect of ceruloplasmin on iron release from placental (BeWo) cells; evidence for an endogenous Cu oxidase. Placenta 2000; 21:805-12. [PMID: 11095930 DOI: 10.1053/plac.2000.0582] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
The mechanism of iron release from the placenta into the fetal circulation is not well understood. Ceruloplasmin, a plasma ferroxidase, has been implicated in iron efflux from a variety of cell types. The hypothesis is that circulating ceruloplasmin facilitates iron efflux by oxidizing the released Fe(II) to Fe(III) for incorporation into transferrin. We tested whether this mechanism mediates iron release from placental cells into the fetal circulation, using the BeWo cell line, a choriocarcinoma which can differentiate into a syncytium.(59)Fe release from undifferentiated or differentiated cells and from cells grown on porous filters was not stimulated by extracellular ceruloplasmin. Instead, we found that BeWo cells express an endogenous ferroxidase. The protein is membrane bound and cross-reacts with an anti-ceruloplasmin antibody, but has a different size; 100 and 140 kDa. Similar immunoreactivity was identified in first- and third-trimester human placentae. In BeWo cells, the protein has a perinuclear localization but does not entirely co-localize with markers for the endoplasmic reticulum or Golgi apparatus. We propose that this oxidase performs the same function as serum ceruloplasmin and is involved in iron release into the fetal circulation.
Collapse
Affiliation(s)
- R Danzeisen
- Rowett Research Institute, Aberdeen, AB21 9SB, UK
| | | | | | | | | | | |
Collapse
|
17
|
Guo M, Sun H, McArdle HJ, Gambling L, Sadler PJ. Ti(IV) uptake and release by human serum transferrin and recognition of Ti(IV)-transferrin by cancer cells: understanding the mechanism of action of the anticancer drug titanocene dichloride. Biochemistry 2000; 39:10023-33. [PMID: 10955990 DOI: 10.1021/bi000798z] [Citation(s) in RCA: 188] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The organometallic anticancer agent titanocene dichloride, Cp(2)TiCl(2), is now in phase II clinical trials as an anticancer drug, but its mechanism of action is poorly understood. We show here that the interactions of Cp(2)TiCl(2) with human serum transferrin (hTF) and that of Ti(2)-hTF with adenosine triphosphate (ATP) have characteristics that could allow transferrin to act as a mediator for titanium delivery to tumor cells. Such reactions may therefore be important to the anticancer activity of this new class of drugs. Cp(2)TiCl(2) reacts rapidly with human apo-transferrin under physiological conditions (100 mM NaCl, 25 mM bicarbonate, and 4 mM phosphate, pH 7.4) with carbonate as a synergistic anion. The Cp ligands are released from the drug. Two-dimensional [(1)H, (13)C] NMR studies of epsilon-[(13)C]Met-hTF show that Ti(IV) loads the C-lobe first followed by the N-lobe and binds in the specific Fe(III) sites. The protein conformational changes induced by Ti(IV) appear to be similar to those induced by Fe(III). Carbonate can act as a synergistic anion in Ti(2)-hTF but does not appear to be essential. A specific Ti(IV)-hTF adduct is formed even in the absence of bicarbonate. When the pH of Ti(2)-hTF solutions is lowered, no Ti(IV) is released at the endosomal pH of ca. 5.0-5.5, but one Ti(IV) dissociates between pH 4.5-2.0. In contrast, in the presence of 1 mM ATP, all Ti(IV) is readily released from both lobes when the pH is lowered from 7.0 to 4.5. Moreover, Fe(III) displaces Ti(IV) rapidly from the C-lobe of Ti(2)-hTF (<5 min) but only slowly (days) from the N-lobe. Thus, the species Fe(C)Ti(N)-hTF might also provide a route for Ti(IV) entry into tumor cells via the transferrin receptor. Ti(2)-hTF effectively blocked cell uptake of radiolabeled (59)Fe-hTF into BeWo cells, a human placental choriocarcinoma cell line in culture. These results imply that titanium transferrin might be recognized by the transferrin receptor and be taken up into cancer cells.
Collapse
Affiliation(s)
- M Guo
- Department of Chemistry, University of Edinburgh, UK
| | | | | | | | | |
Collapse
|
18
|
Abstract
This paper has, given some idea of our concepts of the processes involved in the transport of Cu across cell membranes in the liver, which we have summarised in Fig 1. Cu(II)His2 is reduced to Cu(I). This is transported across the membrane, re-oxidised, either before or after binding to glutathione (Freedman et al., 1989) or HAH1 (Klomp et al., 1997), binds to SAHH, and donates Cu(II) to the ATPase. It is very interesting that cells which are very diverse from an evolutionary point of view still use very similar methods to handle the metal. Whether regulation of transport is also the sam remains to be seen. We would guess that, although there will be strong similarities, there will also be very significant differences, reflecting the different environments seen by different tissues in mammalian cells and given the different requirements of the tissues.
Collapse
Affiliation(s)
- H J McArdle
- Rowett Research Institute, Bucksburn Aberdeen, Scotland.
| | | | | | | |
Collapse
|
19
|
Abstract
The roles that the different vitamins and minerals play in fetal growth and development are reviewed, primarily with respect to growth and differentiation in humans; but, as appropriate, data provided from animal and cellular studies are also considered.
Collapse
Affiliation(s)
- H J McArdle
- Division of Nutrition, Pregnancy and Development, Rowett Research Institute, Aberdeen, UK
| | | |
Collapse
|
20
|
Affiliation(s)
- R J Ward
- Unité de Biochimie, Université Catholique de Louvain, Louvain la Neuve Belgium
| | | | | | | | | |
Collapse
|
21
|
Affiliation(s)
- R Danzeisen
- Rowett Research Institute, Aberdeen, Scotland
| | | |
Collapse
|
22
|
Abstract
The genes responsible for Wilson disease and Menkes syndrome have been cloned and identified as copper ATPases. These enzymes form part of a large family of transporters, the P-type ATPases. Although copper ATPases share strong structural similarities with these other pumps, comparatively little is known about their physiologic function. In this review, we examine data relating to the Wilson disease protein, ATP7B, in the liver. We present evidence suggesting that ATP7B is located intracellularly, together with data suggesting that, at least in part, ATP7B may also be found on the canalicular membrane. We also examine the form of copper that the transporter recognizes. We then review data on the Long-Evans Cinnamon rat, a model for Wilson disease, and discuss what effect the Wilson disease mutation has on copper transport. Finally, we conclude that, although we have made major advances in our understanding of copper metabolism in the liver, there are still many questions awaiting answers.
Collapse
Affiliation(s)
- M J Bingham
- Department of Child Health, Ninewells Hospital and Medical School, University of Dundee, United Kingdom
| | | | | | | | | |
Collapse
|
23
|
Abstract
We report the case of an 1l-y-old boy with a plasma Zn concentration greater than 200 micromol/L, but with symptoms consistent with Zn deficiency. He has had hepatosplenomegaly, rashes, stunted growth (<3rd centile), anemia, and impaired immune function since infancy. He also has vasculitis and osteoporosis. A plasma Zn-binding protein has been separated and characterized by a combination of size exclusion and ion exchange chromatography and electrophoretic studies and by immunologic methods. Antibodies to the partially purified protein have been raised in rabbits. Size exclusion chromatography shows that Zn is bound to a protein with a mass 110000-300000 kD. Electrophoretic and mass spectrometry studies suggest that the protein may be composed of several subunits. One component of the isolated protein reacts with antiserum to alpha2-macroglobulin; immunoprecipitation studies confirm that the protein is not alpha2-macroglobulin or a histidine-rich glycoprotein. Kinetic studies of zinc metabolism in the patient and his mother with stable Zn isotopes show the presence of increased exchangeable Zn, with a rapid flux from plasma to a stable pool. Liver and muscle Zn and Cu concentrations are raised, but with no abnormal liver histology. Immunoreactive metallothionein in the liver is increased. We suggest that this boy may suffer from a previously unrecognized inborn error of Zn metabolism causing symptomatic zinc deficiency.
Collapse
Affiliation(s)
- B Sampson
- Department of Chemical Pathology, Charing Cross Hospital, London, United Kingdom
| | | | | | | | | | | | | | | |
Collapse
|
24
|
Abstract
When hepatocytes are incubated with the chelator diamsar, two pools can be identified, which we have termed extractable and nonextractable. On entering the hepatocyte, 67Cu first associates with the extractable pool and, after approximately 2 h, moves to the nonextractable pool. Both pools demonstrate saturation and are filled as a function of Cu concentration and incubation time. Using the Michaelis-Menten equation, we have estimated the size of the pools after incubation with 67Cu for 30 min and 4 h. During this period the extractable pool decreases in size from 200 +/- 27 to 116 +/- 5 pmol/microgram DNA, whereas the nonextractable pool increases from 28 +/- 9 to 77 +/- 11 pmol/microgram DNA. Movement of Cu from the nonextractable pool to the extractable pool is slow and incomplete. Using [3H]diamsar, we demonstrate that uptake of the chelator is not rate limiting and probably does not occur by pinocytosis. Incubation with diamsar does not affect the activity of superoxide dismutase or cytochrome-c oxidase, although it does prevent the incorporation of 67Cu into ceruloplasmin. Incubation with zinc, which induces metallothionein, results in an increase in 67Cu associated with the nonextractable pool, suggesting that 67Cu-metallothionein constitutes at least part of the nonextractable pool.
Collapse
Affiliation(s)
- M J Bingham
- Department of Child Health, Ninewells Hospital and Medical School, University of Dundee, United Kingdom
| | | | | |
Collapse
|
25
|
Bingham MJ, Ong TJ, Ingledew WJ, McArdle HJ. ATP-dependent copper transporter, in the Golgi apparatus of rat hepatocytes, transports Cu(II) not Cu(I). Am J Physiol 1996; 271:G741-6. [PMID: 8944686 DOI: 10.1152/ajpgi.1996.271.5.g741] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
The Wilson disease adenosinetriphosphatase (ATPase; ATP7B) is believed to bind copper as Cu(I). We provide evidence to suggest that the ATPase actually transports Cu as Cu(II). When the copper is presented to rat liver microsomes as Cu(I), virtually all uptake is ATP independent. If the copper is presented as copper oxalate [Cu(II)], total uptake is reduced to approximately 10% of Cu(I) levels, but ATP-dependent uptake rises, both as a proportion of total uptake and in absolute terms. The reducing agent vitamin C and the Cu(I) chelator bathocuproine both override the effect of oxalate. The data indicate that there are two transporters in the microsomes, an ATP-independent Cu(I) transporter and an ATP-dependent Cu(II) pump. The activity of the Cu(I) transporter correlates most strongly with alkaline phosphatase, suggesting that it is derived from plasma membrane contamination. Cu(II) ATP-dependent transport correlates only with beta-1, 4-galactosyltransferase, which indicates that it is located in the Golgi apparatus.
Collapse
Affiliation(s)
- M J Bingham
- Department of Child Health, Ninewells Hospital and Medical School, University of Dundee, United Kingdom
| | | | | | | |
Collapse
|
26
|
Abstract
The influence of K+ and Ca2+ on Zn2+ transport into cultured human fibroblasts was investigated. Zn2+ uptake was markedly reduced in the presence of both valinomycin and nigericin (electrogenic and electroneutral K+ ionophores, respectively), and by reduction in the transmembrane K+ gradient produced by replacement of extracellular K+ with Na+, suggesting that Zn2+ may be driven by a Zn2+/K+ counter-transport system. To test the counter-transport hypothesis, we used 86Rb as an analog of K+ for efflux studies. The rate of Rb+ efflux was 3760 times that of Zn2+ uptake, thus the component of K+ involved in the Zn2+ counter-transport system was only a small proportion of the total K+ efflux. In investigating the effect of Ca2+ on Zn2+ uptake, we identified two components: (1) a basal Zn2+ uptake pathway, independent of hormonal or growth factors which does not require extracellular Ca2+ and (2) a Ca(2+)-dependent mechanism. The absence of Ca2+ decreased Zn2+ uptake, while increasing extracellular Ca2+ stimulated Zn2+ uptake. The effect was mediated by Ca2+ influx as the ionophores A23187 and ionomycin also stimulated Zn2+ uptake. We could not ascribe the Ca2+ effect to known Ca2+ influx pathways. We conclude that Zn2+ uptake occurs by a K(+)-dependent process, possibly by Zn2+/K+ counter-transport and that a component of this is also Ca(2+)-dependent.
Collapse
Affiliation(s)
- M L Ackland
- Department of Biological and Chemical Sciences, Deakin University, Victoria, Australia
| | | |
Collapse
|
27
|
Abstract
This paper has examined copper uptake from CuHis2 complexes by cytotrophoblast cells isolated from term human placenta. Uptake is time-dependent, reaching equilibrium after about 90 min, and saturable, with a calculated apparent Km of 0.174 +/- 0.061 microM and Vmax, measured over 30 min, of 0.721 +/- 0.092 pmol/min/micrograms DNA. To determine whether ATP was required for uptake, cells were incubated with inhibitors of glycolysis (iodoacetate) and the TCA cycle (sodium azide and cyanide). Iodoacetate and sodium azide had no effect on uptake, but cyanide decreased the initial rate of uptake. This effect was due to copper binding to the inhibitor and decreasing the effective substrate concentration rather than inhibition of uptake through ATP depletion. Ouabain and monensin had no effect, showing that neither the Na+ gradient nor endocytosis were involved in uptake. The monovalent ion chelator, bathocuproine sulphonate, had no effect on uptake but buthionine sulfoximine, an inhibitor of glutathione synthesis, did decrease both the rate of uptake and equilibrium copper levels, suggesting that copper may bind to glutathione within the cell. The data show that copper is taken up by a passive carrier-mediated transporter and, following uptake, binds to glutathione within the cell.
Collapse
Affiliation(s)
- K K Tong
- Department of Child Health, Ninewells Hospital and Medical School, University of Dundee, UK
| | | |
Collapse
|
28
|
Hilton M, Spenser DC, Ross P, Ramsey A, McArdle HJ. Characterisation of the copper uptake mechanism and isolation of the ceruloplasmin receptor/copper transporter in human placental vesicles. Biochim Biophys Acta 1995; 1245:153-60. [PMID: 7492571 DOI: 10.1016/0304-4165(95)00084-o] [Citation(s) in RCA: 25] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
In this paper we have studied copper (Cu) uptake by microvillar vesicles isolated from human term placenta. We have characterised Cu uptake from CuHis2 complexes and shown that ceruloplasmin (Cp) inhibits uptake. Inhibition is complex and variable; in one series of experiments, the Vmax for uptake drops from 31.3 +/- 1.2 nmol/min per mg vesicle protein without added Cp to 11.3 +/- 1 nmol/min per mg vesicle protein at 91 micrograms/ml Cp. Similarly, the K0.5 increases from 0.35 +/- 0.08 microM to 1.35 +/- 0.25 microM, while the n value (the Hill coefficient) falls from 1.9 +/- 0.23 in the absence of Cp to 1.1 +/- 0.13 In another series, Cp had no effect below concentrations of about 100 micrograms/ml and in a third series only increased K0.5. The variability in effect seems to be related to the specific activity of the ceruloplasmin, which in turn is related to the copper complexes of the protein. The effect is specific for Cp; apotransferrin and a2-macroglobulin have no effect. 67Cu-labelled ceruloplasmin binds specifically to vesicles of term placenta with an affinity of 2.8 microU/mg vesicle protein and a Bmax of 79 microU/mg vesicle protein. CuHis2, but not histidine alone, can block the uptake. The data can be reconciled by proposing that the binding site of the transporter is relatively small and recognises a Cu-dihistidine structure common to the low-molecular-weight complex and to the Type I and Type II coppers of ceruloplasmin. We have used these observations to develop an isolation method for the transporter and have identified it as a protein of M(r) 90,000 which is closely associated with alkaline phosphatase. There are also two proteins of M(r) 45,000 and 40,000 which may be breakdown products of the larger complex. Antibodies to the 45,000 protein block Cu binding and uptake from CuHis2 complexes, strongly implicating it as the copper transporter/ceruloplasmin receptor of human term placenta.
Collapse
Affiliation(s)
- M Hilton
- Department of Child Health, Ninewells Hospital and Medical School, University of Dundee, Scotland, UK
| | | | | | | | | |
Collapse
|
29
|
Ong TJ, Kemp PJ, Oliver RE, McArdle HJ. Characterization of zinc uptake and its regulation by arachidonic acid in fetal type II pneumocytes. Am J Physiol 1995; 269:L71-7. [PMID: 7631817 DOI: 10.1152/ajplung.1995.269.1.l71] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
In freshly isolated fetal guinea pig type II pneumocytes, zinc uptake is time and temperature dependent. Two pathways of uptake exist, resulting in a rapid phase that reaches a steady state within 30 s and a slower linear phase that does not attain a steady state within 60 min. Both processes exhibit saturation kinetics. The rapid phase has a maximal zinc uptake of 60.7 +/- 9.3 pmol.10(6) cells-1.30 s-1 and an apparent affinity (Kt) of 13.7 +/- 5.4 microM. The maximum velocity of uptake (Vmax) of the slower phase is 24.6 +/- 1.9 pmol.10(6) cells-1.min-1 with a Kt of 22.0 +/- 3.6 microM. Epinephrine, terbutaline, dibutyryl adenosine 3',5'-cyclic monophosphate, and dexamethasone have no significant effect on zinc uptake, while arachidonic acid (AA) stimulates. Dose-response data of AA-stimulated zinc uptake gives an apparent K0.5 of 0.42 +/- 0.01 microM and a Hill coefficient of 1. The maximal uptake in the rapid phase is significantly increased to 146.8 +/- 12.4 pmol.10(6) cells-1.30 s-1 and in the slow phase, the Vmax for zinc uptake is also significantly increased to 33.0 +/- 1.8 pmol.10(6) cells-1.min-1 by 10 microM AA. However, the Kt values in both processes remain unchanged after AA stimulation. The effect is not mediated by either leukotrienes or prostaglandins but can be mimicked by other unsaturated fatty acids.
Collapse
Affiliation(s)
- T J Ong
- University of Dundee, Department of Child Health, Ninewells Hospital and Medical School, United Kingdom
| | | | | | | |
Collapse
|
30
|
Bingham MJ, Burchell A, McArdle HJ. Identification of an ATP-dependent copper transport system in endoplasmic reticulum vesicles isolated from rat liver. J Physiol 1995; 482 ( Pt 3):583-7. [PMID: 7738849 PMCID: PMC1157784 DOI: 10.1113/jphysiol.1995.sp020542] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Abstract
1. This paper identifies and characterizes an ATP-dependent copper transport system in endoplasmic reticulum vesicles isolated from male rat liver. 2. The transporter has a Km of 2.5 +/- 1.2 mumol 1(-1) copper glutathione (CuGSH) and a Vmax of 4.5 +/- 1.3 nmol (mg protein)-1 (5 min)-1 for copper. 3. At a copper concentration of 2 mumol l-1, ATP dependence reaches saturation, with a Km for ATP of 4.7 +/- 2.4 mmol l-1 and a Vmax of 2.8 +/- 0.6 nmol (mg protein)-1 (5 min)-1. 4. The uptake is dependent on ATP hydrolysis, since a low energy analogue of ATP, adenosine 5'-[beta-gamma-methylene] triphosphate tetralithium (AMP.PCP), has no effect on copper uptake. 5. The transporter is a P-type ATPase, since vanadate inhibits uptake with a high degree of specificity (100 mumol l-1 inhibits uptake by 50% at a copper concentration of 2 mumol l-1).
Collapse
Affiliation(s)
- M J Bingham
- Department of Child Health, University of Dundee, UK
| | | | | |
Collapse
|
31
|
van den Berg GJ, McArdle HJ. A plasma membrane NADH oxidase is involved in copper uptake by plasma membrane vesicles isolated from rat liver. Biochim Biophys Acta 1994; 1195:276-80. [PMID: 7947921 DOI: 10.1016/0005-2736(94)90267-4] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
The accumulation of copper (Cu) by hepatocytes is initiated by the binding of Cu in either a CuHis2 complex or as a CuHisAlb ternary complex, followed by transfer of the metal alone across the cell membrane. In this paper, we provide evidence that the transfer involves reduction of cupric (Cu(II)) copper to cuprous (Cu(I)) copper and further we show that membrane-bound NADH oxidase can provide the electron required for the reduction. 64Cu uptake by rat liver plasma membrane vesicles is stimulated by the addition of NADH, but not NAD+. The stimulation increases the Vmax from 4.75 +/- 0.02 to 8.38 +/- 0.40 nmol Cu/mg protein per min (P < 0.05, mean +/- S.E., n = 3) without significantly altering the K0.5 (1.52 +/- 0.17 and 2.10 +/- 0.22 mumol/l; with n values of 1.30 +/- 0.01 and 1.43 +/- 0.10, respectively; analysing by the Hill equation). Correspondingly, addition of CuHis2 stimulated NADH-oxidase activity by a maximum of 7.4 +/- 2.1 nmol/mg protein per min (P < 0.01, mean +/- S.E., n = 5) at 5 mumol/l and a NADH concentration of 150 mumol/l. Ascorbic acid also stimulated copper uptake, and points to a reductive dissociation of copper prior to its movement into the cell. Our data indicate that membrane bound enzymes can provide an electron for the reduction of copper prior to uptake and suggest a physiological role for the plasma membrane NADH oxidase.
Collapse
Affiliation(s)
- G J van den Berg
- Interfaculty Reactor Institute, Delft University of Technology, The Netherlands
| | | |
Collapse
|
32
|
Abstract
We studied copper uptake from copper dihistidine complexes by plasma membrane vesicles isolated from rat liver and compared the data with those for uptake under the same conditions by hepatocytes cultured from rat liver to determine whether membrane vesicles can be used to study copper uptake. Marker enzyme analysis showed a 28-fold increase in 5'-nucleotidase activity, a slight increase in endoplasmic reticulum and no contamination with mitochondrial membranes. Copper uptake by vesicles is temperature dependent, and solubilization with Triton X-100 results in a loss of accumulative capacity. Increasing osmotic pressure resulted in a decrease in copper levels in the vesicles at equilibrium, showing that uptake--as opposed to binding by the vesicles--occurred. Uptake by vesicles is concentration dependent, with evidence for cooperation in the uptake sites. The substrate concentration yielding 10% maximum uptake was 4.01 +/- 0.5 mumol/L, maximum uptake was 10.8 +/- 0.4 nmol/Cu/mg protein.min and the n value was 1.5 +/- 0.2. In contrast, uptake by cells showed no cooperation (n = 1.09 +/- 0.06) and a significantly higher apparent Michaelis-Menten constant (17.4 +/- 1.3 mumol/L). As expected, the maximum uptake was lower in the hepatocytes (1.82 +/- 0.08 nmol/mg protein.min). Albumin, N-ethylmaleimide and zinc all inhibited uptake in vesicles and in hepatocytes, and the degrees of inhibition were similar in both types of preparation. Vitamin C stimulated uptake in both vesicles and hepatocytes; again, there was a correlation between the increase in uptake at different concentrations. However, cadmium inhibited uptake and nickel stimulated uptake in vesicles and neither metal had any effect in hepatocytes.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- M J Bingham
- Department of Child Health, University of Dundee, Ninewells Hospital and Medical School, United Kingdom
| | | |
Collapse
|
33
|
Lindsay Y, Duthie LM, McArdle HJ. Zinc levels in the rat fetal liver are not determined by transport across the placental microvillar membrane or the fetal liver plasma membrane. Biol Reprod 1994; 51:358-65. [PMID: 7803607 DOI: 10.1095/biolreprod51.3.358] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
During pregnancy, zinc (Zn) levels in the rat fetal liver increase markedly. Why they do so or how the increase is regulated is unknown. We firstly investigated whether the increase occurs as a result of increased Zn transfer across the placenta and then tested whether the regulation occurred at the level of the microvillar membrane of the placenta or the fetal liver plasma membrane. Rats at different stages of gestation were injected with 7.5 microCi 65Zn in 100 microliters rat serum and killed after 1 h. 65Zn levels in the fetus remained constant at equivalent to the amount in 50 microliters maternal plasma per fetus until Day 18; at this time they increased to equivalent to 1.33 ml and then continued to increase until term. We isolated placental microvillar vesicles from placentas at each stage of gestation, characterized them, and measured Zn uptake. Zn uptake rates did not change during pregnancy. Similarly, we isolated vesicles from fetal liver plasma membrane and measured Zn uptake. Again, the uptake properties did not change during pregnancy. The data suggest that some other step in the transport process is rate limiting and that the increase in Zn levels in the fetal liver that occurs during pregnancy is possibly a result, rather than a cause, of metallothionein induction.
Collapse
Affiliation(s)
- Y Lindsay
- Department of Child Health, University of Dundee Ninewells Hospital and Medical School, United Kingdom
| | | | | |
Collapse
|
34
|
Affiliation(s)
- G Arnott
- Department of Child Health, Ninewells Hospital, Dundee, Scotland, United Kingdom
| | | | | | | |
Collapse
|
35
|
Abstract
Systematic studies have been undertaken to compare the effects of cell lysis and chromatography conditions on the observed distribution of Cu amongst Cu-binding proteins in cultured cells. The variables included rate of centrifugation, presence or absence of non-ionic detergent, and presence or absence of dithiothreitol. The application of an improved FPLC gel filtration system has permitted us to examine the effects of the addition of exogenous metallothionein (MT) to cell extracts. When the cell extract contains low levels of endogenous MT, the addition of MT in the presence of dithiothreitol causes a shift of copper to the MT peak. High levels of MT can therefore remove copper from other Cu-binding ligands during cell homogenization, hence producing artifactual Cu distribution results. The use of an anaerobic buffer system has greatly reduced the observed level of Cu exchange, and has allowed comparison of Cu distribution in normal cells and cells from patients with Menkes' disease.
Collapse
Affiliation(s)
- R A Farrell
- Department of Genetics, University of Melbourne, Victoria, Australia
| | | | | |
Collapse
|
36
|
Affiliation(s)
- H J McArdle
- Department of Child Health, Ninewells Hospital and Medical School, Dundee
| |
Collapse
|
37
|
Abstract
The mechanism of zinc (Zn) uptake by microvillous membrane vesicles prepared from human term placenta has been studied. The uptake was complex, with two processes being identified. In the first process, uptake was rapid, reaching equilibrium within 2 min, and was temperature dependent, with a Q10 of 1.5. Equilibrium Zn levels were sensitive to osmotic pressure, with Zn binding at infinite osmolarity being 69% iso-osmotic value. The uptake was saturable, with a Vmax of 58 +/- 2 nmol/mg protein/min and an apparent Kt of 128 +/- 13 microM. Uptake was inhibited by increasing extravesicular K+ concentration, dropping from 0.91 +/- 0.03 nmol/mg/min at 0 extravesicular K+ to 0.47 +/- 0.03 at an extravesicular K+ concentration of 150 mM ([Zn] = 1.0 microM). In the presence of both valinomycin, an electrogenic ionophore, and nigericin, an electroneutral exchanger, an outwardly directed K+ gradient stimulated Zn uptake. Similarly, preloading vesicles with Zn and imposing an inward gradient resulted in a temperature dependent efflux of Zn. The data suggest that there is a K+ dependent Zn transporter in vesicle membranes, and we suggest that the evidence is biased in favour of a Zn/K+ exchanger rather than Zn being dependent on the membrane potential.
Collapse
Affiliation(s)
- N Aslam
- Department of Child Health, University of Dundee, Ninewells Hospital and Medical School, Scotland
| | | |
Collapse
|
38
|
Abstract
Copper uptake from copper-dihistidine complexes by microvillar vesicles from human placenta was studied. Uptake occurred in two phases: a rapid initial binding followed by approximately linear uptake to equilibrium at approximately 5 min. The uptake showed temperature dependence, was saturable (apparent Vmax 10.5 +/- 1.6 nmol/(mg protein.4 min), apparent Km of 0.6 +/- 0.12 mumol/L) and decreased with increasing osmotic pressure, showing that the Cu uptake arose from accumulation within the vesicles and not from extravesicular binding or isotope exchange. Ceruloplasmin blocked uptake of 64Cu from 64Cu-dihistidine by the vesicles, with 50% inhibition achieved at a protein concentration of 5-10 mumol/L and a 64Cu-dihistidine concentration of 1.5 mumol/L. The effect was specific, because glucose oxidase, a noncopper protein, increased apparent uptake by binding copper and in turn being bound to the nitrocellulose membranes used to separate vesicles from incubation medium. Adding increasing concentrations of histidine also decreased uptake. The data presented indicate that the placenta can accumulate copper from copper-dihistidine, that ceruloplasmin can interfere with uptake and that this system will be very valuable in elucidating the first stage in transfer of copper across the placenta.
Collapse
Affiliation(s)
- H J McArdle
- Development, Department of Child Health, University of Dundee, Ninewells Hospital and Medical School, Scotland, U.K
| | | |
Collapse
|
39
|
Abstract
Accumulation of 64Cu in the 14-d mouse fetus was measured following intravenous injection of the dam with 64CuHis2. Concentration of 64Cu in the placenta increased rapidly over the first 4 h, thereafter remaining constant. Transfer to the fetus was linear over 48 h with little evidence of storage in the liver. Maternal serum levels decreased initially, concurrently with increased 64Cu levels in the maternal liver, but did not subsequently increase. Immediately following injection, as much as 40% of the radioactivity was in the nonalbumin fraction, and approximately 37% of that fraction (18% of total) was greater than 30,000 molecular weight. After 24 h, up to 60% of the 64Cu was still found in the albumin peak. The data suggest that the fetus can obtain its Cu from maternal ceruloplasmin but does not exclude the possibility that transfer occurs from the exchangeable (albumin/amino acid) Cu pool of the maternal plasma. In a second experiment, mice at different stages of gestation were injected with 64Cu and killed 4 h later. Total Cu levels and 64Cu uptake into the maternal tissues or into the placenta did not change with increasing gestation. Both total Cu and 64Cu uptake in the fetus and fetal liver increased to a maximum on d 16. Levels in the liver decreased thereafter to term, whereas levels in the rest of the fetus remained approximately constant. The pattern was similar whether the results were expressed per organ or per gram of fresh weight.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- H J McArdle
- Department of Child Health, Ninewells Hospital, Scotland, United Kingdom
| | | |
Collapse
|
40
|
Abstract
Extracellular zinc (Zn)-binding ligands were investigated as vehicles for uptake of Zn by human fibroblasts. The uptake of alpha 2-macroglobulin, a major serum Zn-binding protein proposed to have a function in Zn transport, was less than 1/200 that of the Zn uptake rate. The fibroblast growth medium, BME with 10% FBS, contains several Zn-binding ligands. These were separated into components of MW greater than 30,000 and components of MW less than 30,000 using an Amicon microconcentrator. Cells accumulated Zn from both fractions; however, there was more uptake from the filtrate (MW less than 30,000), containing ligands with low affinity for Zn, hence with greater free Zn concentration. Zn uptake from a number of ligands with a range of affinities for Zn was examined and found to be inversely proportional to the Ka value for the ligands and therefore proportional to the free Zn concentration. When histidine and desferrioxamine, two structurally different Zn-binding ligands were compared, analysis of the concentration curves of calculated free Zn against Zn uptake gave similar Vmax and Km values (+/- S.E.M.) of 373 +/- 6 pmol/micrograms DNA/h and 0.08 +/- 0.004 microM for histidine, and 349 +/- 10 pmol/micrograms DNA/h and 0.06 +/- 0.008 microM for DFO, suggesting that the same transport mechanism was operating in both systems. We conclude that no specific ligands are essential for transport of Zn into fibroblasts, but that "free" Zn is acquired by the cell.
Collapse
Affiliation(s)
- M L Ackland
- Murdoch Institute for Research into Birth Defects, Royal Children's Hospital, Parkville, Victoria, Australia
| | | |
Collapse
|
41
|
McArdle HJ, Mercer JF, Sargeson AM, Danks DM. Effects of cellular copper content on copper uptake and metallothionein and ceruloplasmin mRNA levels in mouse hepatocytes. J Nutr 1990; 120:1370-5. [PMID: 2231026 DOI: 10.1093/jn/120.11.1370] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
The intracellular copper content of mouse hepatocytes has been altered by incubating with either increasing amounts of extracellular copper or increasing amounts of diamsar, a copper chelator. Metallothionein 1 (MT1) and MT2 mRNA levels in the cells increased in proportion to the intracellular copper concentration. The degree of stimulation was similar for both MT1 and MT2, with mRNA levels increasing approximately fourfold for a six- to eightfold increase in intracellular copper levels. In contrast, neither copper uptake nor ceruloplasmin mRNA showed any response to intracellular copper levels. Unlike the situation in the rat, there was no clear evidence for saturation of copper uptake. Incubating cells with increasing amounts of 64Cu resulted in a linear increase in the amount taken up over 2 h. The amount of 64Cu accumulated was the same in control and copper-depleted cells, which suggests that neither ceruloplasmin production nor copper uptake is regulated by intracellular copper levels. However, other possibilities, such as the chelators not being able to deplete the pool(s) responsible for the control of ceruloplasmin production or copper uptake, must also be considered.
Collapse
Affiliation(s)
- H J McArdle
- Department of Child Health, Ninewells Hospital, University of Dundee, Scotland, UK
| | | | | | | |
Collapse
|
42
|
Abstract
It is possible, in vitro, to label albumin with copper either exclusively on the specific binding site or partly on the specific site and also on other sites by altering the pH at which the two ligands are mixed. Copper attached exclusively to the specific site is taken up more rapidly than copper attached to that site and others on albumin. The effect is proportional to the amount of copper on the specific site. Additional histidine stimulates uptake irrespective of the copper binding site on albumin. The effect is related to the histidine on position 3 of the albumin, since it is not seen when dog albumin is labeled under the same conditions. The data suggest that the cell recognizes and presumably binds the copper-albumin (CuAlb) complex but may preferentially recognize the ternary complex formed by CuAlb and histidine. We suggest that, in vivo, copper is bound mainly as the ternary complex and that the structure formed, presumably similar to that formed by a copper-histidine complex, is what is actually recognized by the cell. After binding, the albumin and histidine are released, possibly by a reduction step, and the copper is transported across the membrane. If the copper cannot be transported (as occurs when the cells are incubated at 4 degrees C), it blocks further binding of the ternary complex.
Collapse
Affiliation(s)
- H J McArdle
- Scobie and Claire Mackinnon Trace Element Research Group, Murdoch Institute, Royal Children's Hospital, Melbourne, Victoria, Australia
| | | | | | | |
Collapse
|
43
|
McArdle HJ, Kyriakou P, Grimes A, Mercer JF, Danks DM. The effect of D-penicillamine on metallothionein mRNA levels and copper distribution in mouse hepatocytes. Chem Biol Interact 1990; 75:315-24. [PMID: 2379260 DOI: 10.1016/0009-2797(90)90074-w] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Penicillamine increases the levels of metallothionein (MT) mRNA in a time and concentration dependent manner without altering either the rate of copper uptake or the amount of copper within the cell. The effect is dependent on the presence of intracellular copper, however, since depletion of copper by chelators blocks the effect, and does not alter the ability of dexamethasone to stimulate mRNA production. Penicillamine did not alter the distribution of 64Cu in the hepatocytes, as measured by fast protein liquid chromatography (FPLC), although the pattern may be affected by the amount of MT present. The data indicates that penicillamine removes copper from some intermediary ligand, thereby making it available to induce metallothionein. It is possible that this is part of the therapeutic action of the chelator in the treatment of Wilson's disease.
Collapse
Affiliation(s)
- H J McArdle
- Department of Child Health, Ninewells Hospital and Medical School, Dundee, Scotland
| | | | | | | | | |
Collapse
|
44
|
Abstract
Acrodermatitis enteropathica (AE) is a zinc deficiency disease. To date, the only defect has been demonstrated in the gut. We have investigated zinc uptake in fibroblasts established from four unrelated patients with AE using normal skin fibroblasts as controls. Zinc content of AE and control cells was similar (0.3 fmol/cell). Zinc accumulation over 24 h from a complete culture medium was similar in both normal controls and mutant cells. The fraction of zinc removed by Pronase treatment remained constant at 50 pmol/micrograms DNA, whereas the zinc remaining after Pronase treatment accumulated rapidly for 8 h, then more slowly. Analysis of binding data showed no significant difference between AE and control cells, with apparent Ka values of 4-6 X 10(6) M-1 and between 1 and 2 X 10(8) receptors/cell. Analysis of Pronase resistant data showed no difference between the control and the mutant cells with apparent Km values of 0.2-0.3 microM and Vmax values of 17-19 pmol/micrograms DNA/h. No difference in zinc efflux rates was detected. We conclude that the defect that underlies acrodermatitis enteropathica is either not expressed in fibroblasts or cannot be detected under these experimental conditions.
Collapse
Affiliation(s)
- M L Ackland
- Scobie and Claire Mackinnon Trace Element Research Group, Murdoch Institute for Research into Birth Defects, Royal Children's Hospital, Parkville, Victoria, Australia
| | | | | |
Collapse
|
45
|
Abstract
Tetrathiomolybdate (TTM) has been examined for its effect on copper metabolism in mouse hepatocytes in primary culture and human fibroblasts. It decreased the amount of copper inside hepatocytes, decreased the rate of copper uptake by hepatocytes in a concentration dependent manner, and increased the copper efflux from the cells. TTM appeared to remove copper preferentially from the labile pool, but with a lower affinity than cage chelators. In fibroblasts, TTM only had a marginal effect on copper levels below a concentration of 100 microM and had no clear effect on the rate of copper uptake. TTM was not toxic to human fibroblasts, but in some preparations, a concentration of more than 50 microM was toxic to hepatocytes.
Collapse
Affiliation(s)
- H J McArdle
- Claire and Scobie Mackinnon Trace Element Research Group, Murdoch Institute, Royal Childrens' Hospital, Parkville, Melbourne, Australia
| | | | | | | | | |
Collapse
|
46
|
McArdle HJ, Gross SM, Creaser I, Sargeson AM, Danks DM. Effect of chelators on copper metabolism and copper pools in mouse hepatocytes. Am J Physiol 1989; 256:G667-72. [PMID: 2705527 DOI: 10.1152/ajpgi.1989.256.4.g667] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Disorders of copper storage are usually treated by chelation therapy. It is generally thought that the chelators act by mobilizing copper from the liver, hence allowing excretion in the urine. This paper has examined the effect of chelators on copper uptake and storage in mouse hepatocytes. Penicillamine, a clinically important chelator, does not block the uptake of copper or remove copper from hepatocytes. Two other copper chelators, sar and diamsar, which form very stable and kinetically inert Cu2+ complexes by encapsulating the metal ion in an organic cage, were shown to block copper accumulation by the cells and to remove up to 80% of cell-associated copper. They also removed most (approximately 80%) of the 64Cu accumulated by the cells in 30 min, but released only a small percentage (less than 20%) of that accumulated over 18 h. The results show that copper in the hepatocyte can be divided into at least two pools, an easily accessible one, and another, not removable even after long-term incubation with any of the chelators. Most of the copper normally found in the cell appeared to be associated with the former pool.
Collapse
Affiliation(s)
- H J McArdle
- Murdoch Institute for Research into Birth Defects, Royal Children's Hospital, Melbourne, Victoria
| | | | | | | | | |
Collapse
|
47
|
Grimes A, McArdle HJ, Mercer JF. A total extract dot blot hybridization procedure for mRNA quantitation in small samples of tissues or cultured cells. Anal Biochem 1988; 172:436-43. [PMID: 2461115 DOI: 10.1016/0003-2697(88)90466-6] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
A simple method for the estimation of specific mRNA concentrations in small tissue samples (as little as 1 mg) or cultured cells (lower limit 10(5) cells) is described. Guanidine hydrochloride extracts of whole cells or tissues are applied directly onto nitrocellulose and hybridized with the appropriate nick-translated probe. Loading according to DNA content allows expression of the result as concentration per cell. Hybridizing with a ribosomal RNA probe allows expression of results relative to rRNA and estimation of the RNA/DNA ratio in the sample. We describe the application of this procedure to the measurement of ceruloplasmin mRNA in tissues and cultured hepatocytes.
Collapse
Affiliation(s)
- A Grimes
- Murdoch Institute for Research Into Birth Defects, Royal Childrens Hospital, Parkville Victoria, Australia
| | | | | |
Collapse
|
48
|
Abstract
This study has investigated the uptake of copper by mouse hepatocytes. The cells gave similar results whether they were used right after isolation or maintained overnight on collagen-coated dishes. Uptake from cells in suspension followed two phases: an initial rapid binding followed by a linear uptake phase. The two phases were not so easily distinguishable in cells grown in culture where uptake was linear over the first hour. The uptake showed saturation but may not have followed simple kinetics. Histidine stimulated uptake in a concentration-dependent manner, as did some other amino acids, but copper had very little effect on histidine uptake. The process was not dependent on intracellular adenosine triphosphate (ATP), since inhibitors that substantially reduced ATP levels inside the cell did not alter copper uptake. The inhibitors, however, blocked histidine uptake to varying degrees, suggesting that copper and histidine are taken up by different pathways. The uptake was reduced markedly by N-ethyl maleimide, and preincubation of the cells with "Pronase" resulted in a decrease of uptake. A model for the uptake of copper by hepatocytes that incorporates the data presented in this paper with that produced by earlier workers is suggested.
Collapse
Affiliation(s)
- H J McArdle
- Murdoch Institute for Research Into Birth Defects, Royal Children's Hospital, Parkville, Victoria, Australia
| | | | | |
Collapse
|
49
|
Abstract
The mechanisms of zinc uptake from a complete culture medium by human fibroblasts have been studied. The metal is accumulated in a biphasic pattern; an initial rapid phase followed by a slower linear phase. We suggest that the former represents binding to carriers or receptors on the cell surface followed by uptake to within the cell, or at least to a compartment inaccessible to proteolytic digestion. The uptake correlates well with estimates of the zinc requirement of a growing fibroblast. The process of uptake is saturable, with an apparent association constant of 1.1 X 10(7) M-1. Interestingly, there appears to be a very large number of binding sites, 2 X 10(7) per cell. No explanation for this observation is immediately apparent. The mechanism of uptake is not dependent on metabolic energy, or at least on ATP levels within the cell, but N-ethyl maleimide does block uptake in a dose-dependent manner. Weak bases and ionophores, apart from nigericin, do not affect uptake. The results suggest that zinc is not taken up by a receptor-mediated endocytic pathway as has been described for transferrin and iron.
Collapse
Affiliation(s)
- M L Ackland
- Murdoch Institute for Research into Birth Defects, Royal Children's Hospital, Parkville, Victoria, Australia
| | | | | |
Collapse
|
50
|
Abstract
The effect of nicotine on transferrin and iron transport in placental cells has been studied. Nicotine inhibits iron uptake but has little effect on the steady-state levels of transferrin. The effect is temperature and concentration dependent and is not reversible. At a concentration of 15 mM nicotine inhibited transferrin endocytosis by 40%, while iron uptake was decreased by nearly 60%. Nicotine exerted a similar effect on reticulocytes, but other amines, either tertiary or quaternary, had little or no effect on either iron uptake or steady-state intracellular transferrin levels. The results suggest that nicotine acts by blocking uptake, probably by acting as a weak base inhibiting iron release from transferrin, and inhibiting exocytosis with a resultant block of endocytosis. The concentrations required to exert an effect are too high to implicate inhibition of iron transport in the effects of smoking on pregnancy.
Collapse
Affiliation(s)
- H J McArdle
- Raine Centre for the Study of Perinatal and Developmental Biology, University of Western Australia, Nedlands, W.A. 6009
| | | |
Collapse
|